LONDON, April 30 (Reuters) - The chief executive of British
pharmaceutical company AstraZeneca said it will know by
June or July whether a coronavirus vaccine it is working on with
the University of Oxford will be effective or not.
"By June, July we will already have a very good idea of the
direction of travel in terms of its potential efficacy," CEO
Pascal Soriot told BBC radio on Thursday.
"We'll continue working with the Oxford Vaccine Unit to
bring it to patients and to regulatory authorities first of all
as soon as possible," he added.
(Reporting by Kate Holton; editing by Sarah Young)
Astrazeneca (AZN)
